 | • レポートコード：D0804-07319 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、フェブキソスタットの世界市場を広く調査・分析し、今後の市場展望をまとめております。フェブキソスタットの種類別市場規模（40mg、80mg、20mg、120mg）、用途別市場規模（急性痛風、慢性痛風）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Takeda Pharmaceuticals、Teijin Pharma、Alembic Pharmaceuticals、MACLEODS、Mylan、Prinston Pharmaceutical、Sun Pharma、Lupin Limited、Hikma Pharmaceuticals、Hengrui Pharma ・地域別グローバル市場分析 2015年-2020年 ・フェブキソスタットの北米市場（アメリカ、カナダ、メキシコ） ・フェブキソスタットのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・フェブキソスタットのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・フェブキソスタットの南米市場（ブラジル、アルゼンチン） ・フェブキソスタットの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：40mg、80mg、20mg、120mg ・用途別分析：急性痛風、慢性痛風 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Febuxostat market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.9% in the forecast period of 2020 to 2025 and will expected to reach USD 1178.7 million by 2025, from USD 779 million in 2019.
The Febuxostat market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Febuxostat market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Febuxostat market has been segmented into
40mg
80mg
20mg
120mg
By Application, Febuxostat has been segmented into:
Acute Gout
Chronic Gout
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Febuxostat market presented in the report. This section sheds light on the sales growth of different regional and country-level Febuxostat markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Febuxostat market.
The report offers in-depth assessment of the growth and other aspects of the Febuxostat market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Febuxostat Market Share Analysis
Febuxostat competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Febuxostat sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Febuxostat sales, revenue and market share for each player covered in this report.
The major players covered in Febuxostat are:
Takeda Pharmaceuticals
Teijin Pharma
Alembic Pharmaceuticals
MACLEODS
Mylan
Prinston Pharmaceutical
Sun Pharma
Lupin Limited
Hikma Pharmaceuticals
Hengrui Pharma
Among other players domestic and global, Febuxostat market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Febuxostat product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Febuxostat, with price, sales, revenue and global market share of Febuxostat in 2018 and 2019.
Chapter 3, the Febuxostat competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Febuxostat breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Febuxostat market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Febuxostat sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Febuxostat Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Febuxostat Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 40mg
1.2.3 80mg
1.2.4 20mg
1.2.5 120mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Febuxostat Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Acute Gout
1.3.3 Chronic Gout
1.4 Overview of Global Febuxostat Market
1.4.1 Global Febuxostat Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Takeda Pharmaceuticals
2.1.1 Takeda Pharmaceuticals Details
2.1.2 Takeda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Takeda Pharmaceuticals SWOT Analysis
2.1.4 Takeda Pharmaceuticals Product and Services
2.1.5 Takeda Pharmaceuticals Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Teijin Pharma
2.2.1 Teijin Pharma Details
2.2.2 Teijin Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Teijin Pharma SWOT Analysis
2.2.4 Teijin Pharma Product and Services
2.2.5 Teijin Pharma Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Alembic Pharmaceuticals
2.3.1 Alembic Pharmaceuticals Details
2.3.2 Alembic Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Alembic Pharmaceuticals SWOT Analysis
2.3.4 Alembic Pharmaceuticals Product and Services
2.3.5 Alembic Pharmaceuticals Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 MACLEODS
2.4.1 MACLEODS Details
2.4.2 MACLEODS Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 MACLEODS SWOT Analysis
2.4.4 MACLEODS Product and Services
2.4.5 MACLEODS Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mylan SWOT Analysis
2.5.4 Mylan Product and Services
2.5.5 Mylan Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Prinston Pharmaceutical
2.6.1 Prinston Pharmaceutical Details
2.6.2 Prinston Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Prinston Pharmaceutical SWOT Analysis
2.6.4 Prinston Pharmaceutical Product and Services
2.6.5 Prinston Pharmaceutical Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sun Pharma
2.7.1 Sun Pharma Details
2.7.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sun Pharma SWOT Analysis
2.7.4 Sun Pharma Product and Services
2.7.5 Sun Pharma Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lupin Limited
2.8.1 Lupin Limited Details
2.8.2 Lupin Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lupin Limited SWOT Analysis
2.8.4 Lupin Limited Product and Services
2.8.5 Lupin Limited Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Hikma Pharmaceuticals
2.9.1 Hikma Pharmaceuticals Details
2.9.2 Hikma Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Hikma Pharmaceuticals SWOT Analysis
2.9.4 Hikma Pharmaceuticals Product and Services
2.9.5 Hikma Pharmaceuticals Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hengrui Pharma
2.10.1 Hengrui Pharma Details
2.10.2 Hengrui Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Hengrui Pharma SWOT Analysis
2.10.4 Hengrui Pharma Product and Services
2.10.5 Hengrui Pharma Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Febuxostat Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Febuxostat Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Febuxostat Manufacturer Market Share in 2019
3.3.2 Top 6 Febuxostat Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Febuxostat Sales, Revenue and Market Share by Regions
4.1.1 Global Febuxostat Sales and Market Share by Regions (2015-2020)
4.1.2 Global Febuxostat Revenue and Market Share by Regions (2015-2020)
4.2 North America Febuxostat Sales and Growth Rate (2015-2020)
4.3 Europe Febuxostat Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Febuxostat Sales and Growth Rate (2015-2020)
4.5 South America Febuxostat Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Febuxostat Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Febuxostat Sales, Revenue and Market Share by Country
5.1.1 North America Febuxostat Sales and Market Share by Country (2015-2020)
5.1.2 North America Febuxostat Revenue and Market Share by Country (2015-2020)
5.2 United States Febuxostat Sales and Growth Rate (2015-2020)
5.3 Canada Febuxostat Sales and Growth Rate (2015-2020)
5.4 Mexico Febuxostat Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Febuxostat Sales, Revenue and Market Share by Country
6.1.1 Europe Febuxostat Sales and Market Share by Country (2015-2020)
6.1.2 Europe Febuxostat Revenue and Market Share by Country (2015-2020)
6.2 Germany Febuxostat Sales and Growth Rate (2015-2020)
6.3 UK Febuxostat Sales and Growth Rate (2015-2020)
6.4 France Febuxostat Sales and Growth Rate (2015-2020)
6.5 Russia Febuxostat Sales and Growth Rate (2015-2020)
6.6 Italy Febuxostat Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Febuxostat Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Febuxostat Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Febuxostat Revenue and Market Share by Regions (2015-2020)
7.2 China Febuxostat Sales and Growth Rate (2015-2020)
7.3 Japan Febuxostat Sales and Growth Rate (2015-2020)
7.4 Korea Febuxostat Sales and Growth Rate (2015-2020)
7.5 India Febuxostat Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Febuxostat Sales and Growth Rate (2015-2020)
7.7 Australia Febuxostat Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Febuxostat Sales, Revenue and Market Share by Country
8.1.1 South America Febuxostat Sales and Market Share by Country (2015-2020)
8.1.2 South America Febuxostat Revenue and Market Share by Country (2015-2020)
8.2 Brazil Febuxostat Sales and Growth Rate (2015-2020)
8.3 Argentina Febuxostat Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Febuxostat Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Febuxostat Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Febuxostat Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Febuxostat Sales and Growth Rate (2015-2020)
9.3 Turkey Febuxostat Sales and Growth Rate (2015-2020)
9.4 Egypt Febuxostat Sales and Growth Rate (2015-2020)
9.5 South Africa Febuxostat Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Febuxostat Sales and Market Share by Type (2015-2020)
10.2 Global Febuxostat Revenue and Market Share by Type (2015-2020)
10.3 Global Febuxostat Price by Type (2015-2020)
11 Global Febuxostat Market Segment by Application
11.1 Global Febuxostat Sales Market Share by Application (2015-2020)
11.2 Global Febuxostat Revenue Market Share by Application (2015-2020)
11.3 Global Febuxostat Price by Application (2015-2020)
12 Market Forecast
12.1 Global Febuxostat Sales, Revenue and Growth Rate (2021-2025)
12.2 Febuxostat Market Forecast by Regions (2021-2025)
12.2.1 North America Febuxostat Market Forecast (2021-2025)
12.2.2 Europe Febuxostat Market Forecast (2021-2025)
12.2.3 Asia-Pacific Febuxostat Market Forecast (2021-2025)
12.2.4 South America Febuxostat Market Forecast (2021-2025)
12.2.5 Middle East & Africa Febuxostat Market Forecast (2021-2025)
12.3 Febuxostat Market Forecast by Type (2021-2025)
12.3.1 Global Febuxostat Sales Forecast by Type (2021-2025)
12.3.2 Global Febuxostat Market Share Forecast by Type (2021-2025)
12.4 Febuxostat Market Forecast by Application (2021-2025)
12.4.1 Global Febuxostat Sales Forecast by Application (2021-2025)
12.4.2 Global Febuxostat Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Febuxostat Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Febuxostat by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Febuxostat Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Pharmaceuticals Febuxostat Major Business
Table 9. Takeda Pharmaceuticals Febuxostat Total Revenue (USD Million) (2017-2018)
Table 10. Takeda Pharmaceuticals SWOT Analysis
Table 11. Takeda Pharmaceuticals Febuxostat Product and Services
Table 12. Takeda Pharmaceuticals Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Teijin Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Teijin Pharma Febuxostat Major Business
Table 15. Teijin Pharma Febuxostat Total Revenue (USD Million) (2017-2018)
Table 16. Teijin Pharma SWOT Analysis
Table 17. Teijin Pharma Febuxostat Product and Services
Table 18. Teijin Pharma Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Alembic Pharmaceuticals Febuxostat Major Business
Table 21. Alembic Pharmaceuticals Febuxostat Total Revenue (USD Million) (2017-2018)
Table 22. Alembic Pharmaceuticals SWOT Analysis
Table 23. Alembic Pharmaceuticals Febuxostat Product and Services
Table 24. Alembic Pharmaceuticals Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. MACLEODS Basic Information, Manufacturing Base and Competitors
Table 26. MACLEODS Febuxostat Major Business
Table 27. MACLEODS Febuxostat Total Revenue (USD Million) (2017-2018)
Table 28. MACLEODS SWOT Analysis
Table 29. MACLEODS Febuxostat Product and Services
Table 30. MACLEODS Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Febuxostat Major Business
Table 33. Mylan Febuxostat Total Revenue (USD Million) (2017-2018)
Table 34. Mylan SWOT Analysis
Table 35. Mylan Febuxostat Product and Services
Table 36. Mylan Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Prinston Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Prinston Pharmaceutical Febuxostat Major Business
Table 39. Prinston Pharmaceutical Febuxostat Total Revenue (USD Million) (2017-2018)
Table 40. Prinston Pharmaceutical SWOT Analysis
Table 41. Prinston Pharmaceutical Febuxostat Product and Services
Table 42. Prinston Pharmaceutical Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharma Febuxostat Major Business
Table 45. Sun Pharma Febuxostat Total Revenue (USD Million) (2017-2018)
Table 46. Sun Pharma SWOT Analysis
Table 47. Sun Pharma Febuxostat Product and Services
Table 48. Sun Pharma Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Lupin Limited Basic Information, Manufacturing Base and Competitors
Table 50. Lupin Limited Febuxostat Major Business
Table 51. Lupin Limited Febuxostat Total Revenue (USD Million) (2017-2018)
Table 52. Lupin Limited SWOT Analysis
Table 53. Lupin Limited Febuxostat Product and Services
Table 54. Lupin Limited Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Hikma Pharmaceuticals Febuxostat Major Business
Table 57. Hikma Pharmaceuticals Febuxostat Total Revenue (USD Million) (2017-2018)
Table 58. Hikma Pharmaceuticals SWOT Analysis
Table 59. Hikma Pharmaceuticals Febuxostat Product and Services
Table 60. Hikma Pharmaceuticals Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Hengrui Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Hengrui Pharma Febuxostat Major Business
Table 63. Hengrui Pharma Febuxostat Total Revenue (USD Million) (2017-2018)
Table 64. Hengrui Pharma SWOT Analysis
Table 65. Hengrui Pharma Febuxostat Product and Services
Table 66. Hengrui Pharma Febuxostat Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Febuxostat Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Febuxostat Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Febuxostat Sales by Regions (2015-2020) (K MT)
Table 70. Global Febuxostat Sales Market Share by Regions (2015-2020)
Table 71. Global Febuxostat Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Febuxostat Sales by Countries (2015-2020) (K MT)
Table 73. North America Febuxostat Sales Market Share by Countries (2015-2020)
Table 74. North America Febuxostat Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Febuxostat Revenue Market Share by Countries (2015-2020)
Table 76. Europe Febuxostat Sales by Countries (2015-2020) (K MT)
Table 77. Europe Febuxostat Sales Market Share by Countries (2015-2020)
Table 78. Europe Febuxostat Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Febuxostat Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Febuxostat Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Febuxostat Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Febuxostat Sales by Countries (2015-2020) (K MT)
Table 83. South America Febuxostat Sales Market Share by Countries (2015-2020)
Table 84. South America Febuxostat Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Febuxostat Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Febuxostat Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Febuxostat Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Febuxostat Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Febuxostat Revenue Market Share by Countries (2015-2020)
Table 90. Global Febuxostat Sales by Type (2015-2020) (K MT)
Table 91. Global Febuxostat Sales Share by Type (2015-2020)
Table 92. Global Febuxostat Revenue by Type (2015-2020) (USD Million)
Table 93. Global Febuxostat Revenue Share by Type (2015-2020)
Table 94. Global Febuxostat Sales by Application (2015-2020) (K MT)
Table 95. Global Febuxostat Sales Share by Application (2015-2020)
Table 96. Global Febuxostat Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Febuxostat Market Share Forecast by Regions (2021-2025)
Table 98. Global Febuxostat Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Febuxostat Market Share Forecast by Type (2021-2025)
Table 100. Global Febuxostat Sales Forecast by Application (2021-2025)
Table 101. Global Febuxostat Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Febuxostat Picture
Figure 2. Global Sales Market Share of Febuxostat by Type in 2019
Figure 3. 40mg Picture
Figure 4. 80mg Picture
Figure 5. 20mg Picture
Figure 6. 120mg Picture
Figure 7. Febuxostat Sales Market Share by Application in 2018
Figure 8. Acute Gout Picture
Figure 9. Chronic Gout Picture
Figure 10. Global Febuxostat Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Febuxostat Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Febuxostat Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Febuxostat Sales Market Share by Manufacturer in 2019
Figure 31. Global Febuxostat Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Febuxostat Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Febuxostat Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Febuxostat Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Febuxostat Revenue Market Share by Regions (2015-2020)
Figure 38. Global Febuxostat Revenue Market Share by Regions in 2018
Figure 39. North America Febuxostat Sales and Growth Rate (2015-2020)
Figure 40. Europe Febuxostat Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Febuxostat Sales and Growth Rate (2015-2020)
Figure 42. South America Febuxostat Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Febuxostat Sales and Growth Rate (2015-2020)
Figure 44. North America Febuxostat Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Febuxostat Sales Market Share by Countries (2015-2020)
Figure 46. North America Febuxostat Sales Market Share by Countries in 2018
Figure 47. North America Febuxostat Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Febuxostat Revenue Market Share by Countries in 2018
Figure 49. United States Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Febuxostat Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Febuxostat Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Febuxostat Revenue Market Share by Countries in 2019
Figure 55. Germany Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Febuxostat Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Febuxostat Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Febuxostat Revenue Market Share by Regions 2019
Figure 63. China Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Febuxostat Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Febuxostat Sales Market Share by Countries in 2019
Figure 70. South America Febuxostat Revenue Market Share by Countries in 2019
Figure 71. Brazil Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Febuxostat Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Febuxostat Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Febuxostat Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Febuxostat Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Febuxostat Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Febuxostat Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Febuxostat Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Febuxostat Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Febuxostat Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Febuxostat Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Febuxostat Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Febuxostat Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
フェブキソスタット錠の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Febuxostat Tablets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Febuxostat Tablets market …- 尿酸薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Uric Acid Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- ベンズブロマロンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Benzbromarone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Benzbromarone market report pro…
- コルヒチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Colchicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1058.9 million by 2025, from USD 910.5 million in 2019. The Colchicine market report p…
- 慢性完全閉塞カテーテルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Chronic Total Occlusion Catheter market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…